BMPR2 and pulmonary arterial hypertension: Our study tested the hypothesis that a Th2 immune response in the lungs induced in response to a mild antigen would trigger or exacerbate the pulmonary hypertension phenotype in mice carrying a BMPR2 transgene [22] that models a hypomorphic mutation found in a family of patients affected with PAH [22], [24].